You're viewing a public preview of Neurimmune Holding AG Sign up free to access full investment history, financials, executives & more

Neurimmune Holding AG

Inactive
Wagistrasse 13,  Schlieren,  8952,  Switzerland
Sector: Life Science Entity: Private
About Neurimmune Holding AG
According to available private market data, Neurimmune Holding AG operates in the Life Science sector. It is active in the Life Science space. The company is headquartered in Schlieren. Neurimmune Holding AG appears in AcquityData's private market intelligence platform.
Neurimmune Holding AG M&A Activity
# Company Transaction Date Close Date Sector Country
View M&A Acquisitions
Sign up to explore the full acquisition & merger history
Key Executives & Professionals
View Executives & Professionals
Sign up to access board members, senior management & key contacts
Frequently Asked Questions
What does Neurimmune Holding AG do?
According to available private market data, Neurimmune Holding AG operates in the Life Science sector. It is active in the Life Science space. The company is headquartered in Schlieren. Neurimmune Holding AG appears in AcquityData's private market intelligence platform.
Where is Neurimmune Holding AG headquartered?
Neurimmune Holding AG is headquartered in Schlieren, Switzerland.
When was Neurimmune Holding AG founded?
Founded year information for Neurimmune Holding AG is available on AcquityData.
What sector is Neurimmune Holding AG in?
Neurimmune Holding AG operates in the Life Science sector.
Who are the investors in Neurimmune Holding AG?
Investor information for Neurimmune Holding AG is available to AcquityData members. Sign up for free to access full ownership history.
How many M&A transactions has Neurimmune Holding AG been involved in?
Transaction data for Neurimmune Holding AG is available to AcquityData members.

Unlock the full Neurimmune Holding AG profile

Ownership & Investors M&A History Financials Key Executives Advisors & Lenders

Access Neurimmune Holding AG's complete ownership history, M&A activity, investors, advisors and executives in one connected platform.

Start Free Trial